Ronnie Speight | SVP, IR |
Alistair Macdonald | CEO & Director |
Jason Meggs | CFO |
Paul Colvin | President, Clinical Solutions |
Michelle Keefe | President, Commercial Solutions |
Robert Jones | Goldman Sachs Group |
David Windley | Jefferies |
Erin Wright | Crédit Suisse |
Patrick Donnelly | Citigroup |
John Kreger | William Blair & Company |
Elizabeth Anderson | Evercore ISI |
Donald Hooker | KeyBanc Capital Markets |
Daniel Brennan | UBS |
Luke Sergott | Barclays Bank |
Good morning, everyone. With me on the call today are Alistair Macdonald, our Chief Executive Officer; Jason Meggs, our Chief Financial Officer; Michelle Keefe, our President of Commercial Solutions; and Paul Colvin, our President of Clinical Solutions.
In addition to the press release, a slide presentation corresponding to our prepared remarks is available on our website at investor.syneoshealth.com. Remarks that we make about future expectations, plans, growth, anticipated financial results and prospects and our expectations regarding the COVID-19 pandemic constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995, and we disclaim any obligation to update them. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors.